Chandralal Weerasinghe, LLC offers consulting services in the following areas:PREPARATION OF SUITABILITY PETITIONS TO OBTAIN PERMISSIONS FROM FDA TO SUBMIT ANDA/ANADASINTELLECTUAL PROPERTY STRATEGY MANAGEMENTFREEDOM TO OPERATE (FTO) ANALYSISREGULATORY GUIDANCE ON SUBMITTING ANADAs TO US FDA-From JINAD to ApprovalENVIRONMENTAL IMPACT ASSESSMENT (EIA)REGULATORY/COMPLIANCE RELATED TO HUMAN/VETERINARY DRUG DEVELOPMENT:EXPERIENCE AND EXPERTISEChandralal Weerasinghe, Ph.D., has over 24 years in leadership and technical positions at Pfizer, Inc. and SmithKline Beecham Animal Health. Prior to that he managed the trace organic Analysis Group at Midwest Center for Mass Spectrometry attached to University of Nebraska. His expertise spans a diverse area in the pharmaceutical industry starting from molecular profiling, biotransformation, environmental impact assessment, and human food safety to intellectual property strategy management. He held positions with increasing responsibility in both technical and management. He is a strategic thinker with good leadership skills and his cross-functional expertise will help him to provide valuable and customized solutions to a variety of clients who can benefit from his expertise.Specialties: Life cycle management of pharmaceuticals Intellectual property strategy managementMarket exclusivity of drugs and patent term extensionsPatent portfolio management Environmental impact assessment of pharmaceuticalsHuman food safety of animal health drugs. Product defense activities at regulatory agencies, USA and EuropeTrace organic analysis of persistent organochlorines by HRGC/HRMSBioanalytical methods; HPLC, GC, HPLC/MS and GC/MS including wet chemistry